- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, December 15, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A study entitled, “Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes,” to be published in the December 2023 issue of The American Journal of Managed Care® (AJMC®), was referenced in articles from US News & World Report, Medpage Today, Medical News Today, Healio, HealthDay, and Medical Economics®. The study found that approximately 40% of patients with type 2 diabetes discontinued their second-line therapies within a year.
An article from Medriva referenced an article published on AJMC.com, the website of AJMC. The article, “Health Insurance Markets Remain Highly Concentrated in the Majority of US,” covered a report from the American Medical Association that found the market for health insurance, both commercial and Medicare Advantage, became more concentrated from 2014 to 2022.
TNX-102 SL Now Fourth FDA-Approved Treatment for Fibromyalgia
August 18th 2025This approval brings the total to 4 of medications approved to treat fibromyalgia; in addition to cyclobenzaprine HCl sublingual tablets (TNX-102 SL; Tonmya; Tonix Pharmaceuticals), there are pregabalin (Lyrica; Viatris), duloxetine (Cymbalta; Eli Lilly), and milnacipran (Savella; AbbVie).
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
